Skip to Content

Exenatide Extended-Release Suspension for Injection

Last Updated: September 17, 2019
Status: Resolved

Reason for the Shortage
    • AstraZeneca has Bydureon BCise available.
    • AstraZeneca has Bydureon Pen available.
Available Products
    • Bydureon BCise subcutaneous suspension for injection, AstraZeneca, 2 mg, 0.85 mL auto-injector, 4 count, NDC 00310-6540-04
    • Bydureon Pen subcutaneous suspension for injection, AstraZeneca, 2 mg, 0.65 mL pen injector, 4 count, NDC 00310-6530-04

Updated

Updated September 17, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 20, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide